Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Oedema
ADR ID BADD_A03129
ADR Hierarchy
08      General disorders and administration site conditions
08.01      General system disorders NEC
08.01.07      Oedema NEC
08.01.07.006      Oedema
14      Metabolism and nutrition disorders
14.05      Electrolyte and fluid balance conditions
14.05.06      Total fluid volume increased
14.05.06.010      Oedema
Description Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE. [MeSH]
MedDRA Code 10030095
MeSH ID D004487
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Edema | Edema (NOS) | Edema NOS | Edematous weight gain | Inflammatory edema reaction | Inflammatory oedema reaction | Oedema | Oedema like | Oedema NOS | Oedema transient | Oedema-like | Oedematous weight gain | Pitting oedema | Oedema aggravated | Edema aggravated | Edema like | Edema transient | Edema-like | Pitting edema | Chronic edema | Chronic oedema | Weeping edema | Weeping oedema | Idiopathic oedema | Idiopathic edema | Dropsy | Hydrops | Anasarca
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02548Darolutamide0.001301%
BADD_D02553Entrectinib0.000336%
BADD_D02585Pralsetinib0.000224%
BADD_D02593Selpercatinib0.000492%
BADD_D02596Sotorasib0.000817%
BADD_D02599Tepotinib0.000582%
BADD_D02605Vericiguat0.000186%
BADD_D02608Voclosporin0.000530%
BADD_D02609Zanubrutinib0.000627%
BADD_D02617Cephalothin--
BADD_D02624Iodine--
BADD_D02627Methyl salicylate--
BADD_D02630Oxyphenbutazone--
BADD_D02631Phenylbutazone--
BADD_D02636Sulfisoxazole--
The 32th Page    First    Pre   32    Total 32 Pages